News
NeuroQuant® - Translation to Clinical Practice
An article published in Behavioural Neurology (2009) entitled “Fully-automated volumetric MRI with normative ranges: Translation to clinical practice” explains how NeuroQuant®’s fully-automated volumetric MRI capabilities with normative ranges can facilitate wider implementation of volumetric MRI beyond the academic setting.
Measuring Brain Atrophy In Patients With Mild Cognitive Impairment
Scientists at the University of California, San Diego School of Medicine have shown that NeuroQuant® fully automated Volumetric MRI is effective in predicting the progression from mild cognitive impairment (MCI) to Alzheimer's disease. The procedure can be readily used in clinics to measure brain atrophy, and may help physicians to predict decline in MCI patients. Read press release or PubMed citation
NeuroQuant® Results Published in American Journal of Neuroradiology.
Brewer JB, Magda S, Airriess C, Smith ME (2008). Fully-Automated Quantification of Regional Brain Volumes for Improved Detection of Focal Atrophy in Azheimer’s Disease. AJNR Am J Neuroradiology.
NeuroQuant® highlighted on Apple, Inc Science website!
In a feature entitled "Breakthrough: Unmasking Early-Stage Alzheimer's Disease - Reducing MRI Analysis Time from 100 Hours to Less than 10 Minutes" Apple discusses NeuroQuant® and profiles UCSD neuroradiologist Dr James Brewer, who uses NeuroQuant® extensively in his research and clinical practice.
NeuroQuant® Results Presented at the 2008 International Conference on Alzheimer's Disease, Chicago, July 26-31 2008.
Automated volumetric analyses performed with NeuroQuant® were shown to
be highly reliable across repeated imaging sessions and equivalent in
accuracy to volumetric analysis performed by an expert human
neuroanatomist. Results produced by NeuroQuant® were also shown to be
highly sensitive to the medial temporal temporal lobe atrophy
characteristic of early stage Alzheimer's disease.
NeuroQuant® selected as Finalist in 2007 Most Innovative New Product Awards (10/1/07)
CorTechs Labs NeuroQuant® was selected from over ninety nominations in seven categories to be honored through the MIP Awards, celebrating excellence among San Diego innovators and entrepreneurs for the past 20 years. Click here to read the press release.
Press Release (9/20/07)
CorTechs Labs, Inc. Introduces NeuroQuant®: the First Medical Device for Quantifying Regional Brain Atrophy in Patients with Neurodegenerative Disorders
